Allergan Sales LLC — FDA Facility Profile

FEI 1523957

Allergan Sales LLC is an FDA-inspected facility (FEI 1523957) located in Cincinnati, OH, US. RegDataLab tracks 8 FDA inspections at this facility.

Reviewing Allergan Sales LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Allergan Sales LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Jun 24, 2021: Voluntary Action Indicated (VAI)
Inspections on record
8 (6 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 24, 2021Voluntary Action Indicated (VAI)No citations listed
Jul 29, 2019Voluntary Action Indicated (VAI)Retest of approved components/containers/closures (21 CFR 211.87)
Investigations of discrepancies, failures (21 CFR 211.192)
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Scientifically sound laboratory controls (21 CFR 211.160(b))
May 20, 2016No Action Indicated (NAI)No citations listed
Sep 22, 2015No Action Indicated (NAI)No citations listed
Nov 5, 2012Voluntary Action Indicated (VAI)No citations listed
Dec 3, 2010Voluntary Action Indicated (VAI)Strict control not exercised over labeling issued (21 CFR 211.125(a))
Nov 10, 2009Voluntary Action Indicated (VAI)Written procedures not established/followed (21 CFR 211.67(b))
Complaint Handling Procedure (21 CFR 211.198(a))
Jul 10, 2009Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Written procedures not established/followed (21 CFR 211.67(b))
Components withheld from use pending release (21 CFR 211.84(a))
Testing and release for distribution (21 CFR 211.165(a))
and 1 more

Facility details

Company
Allergan Sales LLC
Location
Cincinnati, OH (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.